Hims & Hers Health (HIMS) has made a major change in its PR function with the hiring of Kathryn Beiser, who has served Lilly (LLY) as the weight loss drugmaker’s chief communications officer for five years.
Backed by decades of experience in the PR field, including four CCO roles, Beiser has also served at companies including Kaiser Permanente, Hilton Worldwide (HLT), and, most recently, Lilly (LLY), Hims & Hers (HIMS) CEO Andrew Dudum said in an X post on Tuesday.
“She’s been working with me and our executive leaders now for just a few weeks, but it feels like she’s been part of our team for a decade,” he added.
After joining the company last month as chief communications officer, Beiser will directly report to Dudum, Bloomberg reported.
Beiser said that HIMS is a firm where “collaboration and experimentation is part of everyone’s DNA.” “That’s the kind of environment where I believe change can happen.”
The announcement comes as Hims & Hers (HIMS), a major operator in the market for compounded versions of weight loss drugs, shifts its sales strategy to focus on brand-name obesity drugs following a partnership with Novo Nordisk (NVO).